A prospective study of smoking-related white blood cell DNA methylation markers and risk of bladder cancer
European Journal of Epidemiology · 2024-04 · 39 (4) · 393-407
DOI: 10.1007/s10654-024-01110-y ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Epidemiology, online erschienen am 30.03.2024. Verfasst von Roel Vermeulen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Risk Assessment Sciences, Division of Environmental Epidemiology, Utrecht University, PO Box 80178, 3508 TD, Utrecht, The Netherlands. …. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, DNA Methylation, Smoking. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Division of Cancer Epidemiology and Genetics, National Cancer Institute.
Abstract (Originalsprache)
Bladder cancer, a common neoplasm, is primarily caused by tobacco smoking. Epigenetic alterations including DNA methylation have the potential to be used as prospective markers of increased risk, particularly in at-risk populations such as smokers. We aimed to investigate the potential of smoking-related white blood cell (WBC) methylation markers to contribute to an increase in bladder cancer risk prediction over classical questionnaire-based smoking metrics (i.e., duration, intensity, packyears) in a nested case–control study within the prospective prostate, lung, colorectal, and ovarian (PLCO) Cancer Screening Trial and the alpha-tocopherol, beta-carotene cancer (ATBC) Prevention Study (789 cases; 849 controls). We identified 200 differentially methylated sites associated with smoking status and 28 significantly associated (after correction for multiple testing) with bladder cancer risk among 2670 previously reported smoking-related cytosine–phosphate–guanines sites (CpGs). Similar patterns were observed across cohorts. Receiver operating characteristic (ROC) analyses indicated that cg05575921 (AHHR), the strongest smoking-related association we identified for bladder cancer risk, alone yielded similar predictive performance (AUC: 0.60) than classical smoking metrics (AUC: 0.59–0.62). Best prediction was achieved by including the first principal component (PC1) from the 200 smoking-related CpGs alongside smoking metrics (AUC: 0.63–0.65). Further, PC1 remained significantly associated with elevated bladder cancer risk after adjusting for smoking metrics. These findings suggest DNA methylation profiles reflect aspects of tobacco smoke exposure in addition to those captured by smoking duration, intensity and packyears, and/or individual susceptibility relevant to bladder cancer etiology, warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Risk Assessment Sciences, Division of Environmental Epidemiology, Utrecht University, PO Box 80178, 3508 TD, Utrecht, The Netherlands. r.c.h.vermeulen@uu.nl.
- Faculty of Medicine, School of Public Health, Department of Epidemiology and Biostatistics, Imperial College London, London, UK.
- MRC Centre for Environment and Health, Imperial College London, London, UK.
- Commissariat À L'Energie Atomique Et Aux Énergies Alternatives (CEA), Institut Des Sciences du Vivant Fréderic Joliot, Université Côte d'Azur, Nice, France.
- Immunity Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, RTP, Durham, NC, USA.
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Förderung
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
Zitieren
APA
Vermeulen, R., Bodinier, B., Dagnino, S., Wada, R., Wang, X., Silverman, D., Albanes, D., Freedman, N., Rahman, M., Bell, D., Chadeau-Hyam, M., & Rothman, N. (2024). A prospective study of smoking-related white blood cell DNA methylation markers and risk of bladder cancer. European Journal of Epidemiology, 39(4), 393-407. https://doi.org/10.1007/s10654-024-01110-y
Vancouver
Vermeulen R, Bodinier B, Dagnino S, Wada R, Wang X, Silverman D, et al. A prospective study of smoking-related white blood cell DNA methylation markers and risk of bladder cancer. European Journal of Epidemiology. 2024;39(4):393-407. doi:10.1007/s10654-024-01110-y
BibTeX
@article{Vermeulen2024,
author = {Vermeulen, Roel and Bodinier, Barbara and Dagnino, Sonia and Wada, Rin and Wang, Xuting and Silverman, Debra and Albanes, Demetrius and Freedman, Neal and Rahman, Mohammad and Bell, Douglas and Chadeau-Hyam, Marc and Rothman, Nathaniel},
title = {A prospective study of smoking-related white blood cell DNA methylation markers and risk of bladder cancer},
journal = {European Journal of Epidemiology},
year = {2024},
volume = {39},
number = {4},
pages = {393--407},
doi = {10.1007/s10654-024-01110-y}
}
EUVIMED